LifeNet Health Acquires Tissue Testing Technologies (T3)

December 15, 2025

LifeNet Health has acquired Tissue Testing Technologies LLC (T3), a North Charleston–based biotechnology firm specializing in biopreservation and cryopreservation solutions. The acquisition adds T3’s proprietary preservation technologies and contract research capabilities to LifeNet Health’s regenerative medicine and transplantation platforms to expand clinical reach and accelerate research pipelines.

Buyers
LifeNet Health
Targets
Tissue Testing Technologies LLC
Industry
Biotechnology
Location
South Carolina, United States
Transaction Type
Buyout

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.